Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor Morgan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Organic Letters|February 15, 2002
A solid-phase route to N-cyanoamidesTrevor Morgan, Nicholas C Ray, David M Parry
The Analyst|May 16, 2013
Use of a large Stokes-shift fluorophore to increase the multiplexing capacity of a point-of-care DNA diagnostic deviceJames A Richardson, Trevor Morgan, Michael Andreou, et al.
Drug Discovery Today|June 18, 2013
The background, discovery and clinical development of BCR-ABL inhibitorsGemma K Lambert, Anne-Kathrin Duhme-Klair, Trevor Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2008
IRAK-4 inhibitors. Part 1: a series of amidesGeorge M Buckley, Lewis Gowers, Alicia Perez Higueruelo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug DiscoveryWerngard Czechtizky, Jüergen Dedio, Bimbisar Desai, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
IRAK-4 inhibitors. Part III: a series of imidazo[1,2-a]pyridinesGeorge M Buckley, Richard Fosbeary, Joanne L Fraser, et al.
Journal of Medicinal Chemistry|February 28, 2013
Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platformBimbisar Desai, Karen Dixon, Elizabeth Farrant, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2008
IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine bindingGeorge M Buckley, Thomas A Ceska, Joanne L Fraser, et al.
Journal of Medicinal Chemistry|September 28, 2019
Selective Phenylimidazole-Based Inhibitors of the <i>Mycobacterium tuberculosis</i> ProteasomeWenhu Zhan, Hao-Chi Hsu, Trevor Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2008
Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazinesBenjamin Perry, Rikki Alexander, Gavin Bennett, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Organic Letters|February 15, 2002
A solid-phase route to N-cyanoamidesTrevor Morgan, Nicholas C Ray, David M Parry
The Analyst|May 16, 2013
Use of a large Stokes-shift fluorophore to increase the multiplexing capacity of a point-of-care DNA diagnostic deviceJames A Richardson, Trevor Morgan, Michael Andreou, et al.
Drug Discovery Today|June 18, 2013
The background, discovery and clinical development of BCR-ABL inhibitorsGemma K Lambert, Anne-Kathrin Duhme-Klair, Trevor Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2008
IRAK-4 inhibitors. Part 1: a series of amidesGeorge M Buckley, Lewis Gowers, Alicia Perez Higueruelo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug DiscoveryWerngard Czechtizky, Jüergen Dedio, Bimbisar Desai, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
IRAK-4 inhibitors. Part III: a series of imidazo[1,2-a]pyridinesGeorge M Buckley, Richard Fosbeary, Joanne L Fraser, et al.
Journal of Medicinal Chemistry|February 28, 2013
Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platformBimbisar Desai, Karen Dixon, Elizabeth Farrant, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2008
IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine bindingGeorge M Buckley, Thomas A Ceska, Joanne L Fraser, et al.
Journal of Medicinal Chemistry|September 28, 2019
Selective Phenylimidazole-Based Inhibitors of the <i>Mycobacterium tuberculosis</i> ProteasomeWenhu Zhan, Hao-Chi Hsu, Trevor Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2008
Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazinesBenjamin Perry, Rikki Alexander, Gavin Bennett, et al.
Pageof 2